Transgenic Atlantic salmon, genetically modified to grow larger and faster than wild-type fish, are capable of hybridizing with wild brown trout, creating offspring that carry modified growth genes and outcompete both wild and GM fish, according to new research conducted by Canadian scientists. The modified salmon is poised to become the first GM animal approved for human consumption in the United States, with the US Food and Drug Administration approaching a decision on the product.
"We suggest that interspecific hybridization be explicitly considered when assessing the environmental consequences should transgenic animals escape to nature," wrote the authors of a paper announcing the results in the current issue of Proceedings of the Royal Society B.
AquaBounty, the biotech company that makes the GM salmon (dubbed AquAdvantage), countered that their product consists of female, sterile fish that would be reared in aquaculture facilities on land, making any such risks negligible. "Overall, the study seems to present no new evidence for any added environmental risk associated with the AquAdvantage salmon," AquaBounty CEO Ron Stotish told BBC News.
Read the full story at the Scientist>>
National Fisherman Live: 11/06/14
In this episode:
NOAA report touts 2013 landings, value increases
Panama fines GM salmon company Aquabounty
Gulf council passes Reef Fish Amendment 40
Maine elver quota cut by 2,000 pounds
Offshore mussel farm would be East Coast’s first